News

12
Dec

NativeSkin now available for lab delivery on Mondays!

NativeSkin kit now available for lab delivery on Mondays! We have great news! We have been working hard to optimize our technology and processes this year. We are now able to offer a solution to those seeking to work on our NativeSkin kits throughout the work week. If you order NativeSkin kit, we will prepare and ship them in time for you to receive them on Mondays. Our proprietary
Read more
21
Nov

Genoskin, Inc. renforce son équipe dans la région de Boston

Genoskin, Inc. offre un poste de manager de laboratoire et chef de projet basé à Salem dans la région de Boston (MA), sous la forme d’un Volontariat International en Entreprise (VIE). Venez nous rejoindre ! Rémunération : Compensation nette d’environ 36 K EUR / an + compensation frais hébergement Date de début : Dès que possible Contrat : CDD de 2

Read more

26
Sep

Genoskin signs distribution agreement with Japanese distributor

Genoskin signs distribution agreement with Japan's Fujifilm Wako Pure Chemical The Genoskin team is excited to announce that we've signed an agreement with the Japanese Fujifilm Wako Pure Chemical Corporation to distribute Genoskin's ex vivo human skin models to customers in Japan. This agreement will enable Genoskin to respond to the specific needs of exisiting and potential customers in Japan and to increase its
Read more
6
Sep

New study model for injectable anti-psoriasis drugs

New study model for injectable anti-psoriasis drugs A hi-tech psoriasis skin model to study drug efficacy To evaluate the efficacy of injectable anti-psoriasis drugs, the Genoskin team has designed a new test model that combines the InflammaSkin® and HypoSkin® technologies. Below you’ll find a proof-of-concept case study that illustrates the relevance of the new Hypo-InflammaSkin® model during efficacy studies of injectable
Read more
2
Mar

DBV’s immunotherapy tested on Genoskin’s skin models

DBV Technologies' epicutaneous immunotherapy tested using NativeSkin® ex vivo human skin Latest results to be presented at the AAAAI/WAO Joint Congress in Orlando The poster "Epicutaneous immunotherapy with peanut directly targets Langerhans cells in human skin" (n° 723, session  4204) will be presented at the American Academy of Allergy, Asthma & Immunology (AAAAI)/World Allergy Organization (WAO) Joint Congress in Orlando, Florida on
Read more
22
Feb

Ex vivo human skin models for cosmetic testing

Standardized ex vivo skin models for cosmetic testing Cosmetic testing is playing an increasingly important role in today’s cosmetic industry. The first cosmetic tests took place in 1933, after an eyelash darkening treatment blinded several women. In 1938, the U. S. Food and Drug Administration passed the Federal Food, Drug & Cosmetic (FD&C) Act to define stricter regulations for cosmetic products
Read more